1. Home
  2. ADAP vs LVO Comparison

ADAP vs LVO Comparison

Compare ADAP & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • LVO
  • Stock Information
  • Founded
  • ADAP 2008
  • LVO 2009
  • Country
  • ADAP United Kingdom
  • LVO United States
  • Employees
  • ADAP N/A
  • LVO N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • LVO Restaurants
  • Sector
  • ADAP Health Care
  • LVO Consumer Discretionary
  • Exchange
  • ADAP Nasdaq
  • LVO Nasdaq
  • Market Cap
  • ADAP 75.5M
  • LVO 61.3M
  • IPO Year
  • ADAP 2015
  • LVO N/A
  • Fundamental
  • Price
  • ADAP $0.28
  • LVO $0.74
  • Analyst Decision
  • ADAP Buy
  • LVO Strong Buy
  • Analyst Count
  • ADAP 6
  • LVO 1
  • Target Price
  • ADAP $1.52
  • LVO $1.50
  • AVG Volume (30 Days)
  • ADAP 1.6M
  • LVO 291.3K
  • Earning Date
  • ADAP 05-13-2025
  • LVO 06-10-2025
  • Dividend Yield
  • ADAP N/A
  • LVO N/A
  • EPS Growth
  • ADAP N/A
  • LVO N/A
  • EPS
  • ADAP N/A
  • LVO N/A
  • Revenue
  • ADAP $179,639,000.00
  • LVO $126,016,000.00
  • Revenue This Year
  • ADAP N/A
  • LVO N/A
  • Revenue Next Year
  • ADAP $52.49
  • LVO N/A
  • P/E Ratio
  • ADAP N/A
  • LVO N/A
  • Revenue Growth
  • ADAP 878.53
  • LVO 11.43
  • 52 Week Low
  • ADAP $0.20
  • LVO $0.55
  • 52 Week High
  • ADAP $1.48
  • LVO $1.89
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 49.68
  • LVO 47.58
  • Support Level
  • ADAP $0.26
  • LVO $0.72
  • Resistance Level
  • ADAP $0.30
  • LVO $0.79
  • Average True Range (ATR)
  • ADAP 0.03
  • LVO 0.07
  • MACD
  • ADAP 0.00
  • LVO -0.01
  • Stochastic Oscillator
  • ADAP 54.53
  • LVO 12.76

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About LVO LiveOne Inc.

LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.

Share on Social Networks: